Co-Trimoxazole-Rivopharm

Co-trimoxazole-Rivopharm: combined antimicrobial agent

Co-trimoxazole-Rivopharm is a combination antimicrobial agent produced by the pharmaceutical company Rivopharm SA in Switzerland. It consists of two active ingredients: sulfamethoxazole and trimethoprim.

Sulfamethoxazole and trimethoprim have a synergistic effect, that is, their combined use enhances the therapeutic effect. Sulfamethoxazole is an antibacterial sulfonamide that inhibits the synthesis of amino acids and nucleic acids necessary for bacterial growth. Trimethoprim, in turn, is an antibacterial drug that inhibits the synthesis of folic acid in bacteria.

Co-trimoxazole-Rivopharm is widely used to treat infections of various locations caused by microorganisms sensitive to it. It can be effective against bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, Escherichia coli, Klebsiella pneumoniae, Pneumocystis jirovecii and others.

The drug is available in the form of tablets of various dosages and suspensions for oral administration. The dosage and duration of therapy should be determined by the physician depending on the severity of the infection, age and condition of the patient.

Co-trimoxazole-Rivopharm has some contraindications and side effects that must be taken into account when using it. It is not recommended for hypersensitivity to sulfonamides or trimethoprim, liver or kidney failure, B12 deficiency anemia, agranulocytosis, leukopenia, glucose-6-phosphate dehydrogenase deficiency, pregnancy, lactation and childhood.

Side effects may include disorders of the gastrointestinal tract, hematopoiesis, urinary system, allergic reactions and others. If any unwanted effects occur, you should consult your doctor.

Overall, co-trimoxazole-Rivopharm is an effective antimicrobial agent that is used to treat many infections. However, its use should only be carried out under the supervision of a doctor and in accordance with the instructions in the instructions for the drug.